07.28.15
Sunnyvale, Calif.-based Intuitive Surgical Inc. has added Michael A. Friedman, M.D., to its board of directors.
Friedman is an emeritus Cancer Center director of City of Hope, a Duarte, Calif.-based cancer research, treatment and education institution. He was the president and CEO of City of Hope from May 2003 to December 2013 and holder of the Irell & Manella Cancer Center Director’s Distinguished Chair. Before leading City of Hope, from September 2001 until April 2003, Friedman held the position of senior vice president of research and development, medical and public policy, for Pharmacia Corporation and from July 1999 until September 2001, was a senior vice president of Searle, a subsidiary of Monsanto Company. From 1995 until June 1999, he served as deputy commissioner for operations for the U.S. Food and Drug Administration, and was acting commissioner and lead deputy commissioner from 1997 to 1999.
"Dr. Friedman has tremendous industry experience expertise that will be a valuable addition to Intuitive Surgical Board discussions", said Gary Guthart, Ph.D., president and CEO of Intuitive Surgical. "We look forward to welcoming him to our board."
Friedman has served on the board of directors of Celgene Corporation since February 2011, of MannKind Corporation since December 2003, and of Smith & Nephew plc since April 2013.
He graduated with a bachelor of arts degree, magna cum laude from Tulane University in New Orleans, La., and a doctorate in medicine from the University of Texas. He completed postdoctoral training at Stanford University and the National Cancer Institute, and is board certified in internal medicine and medical oncology.
Intuitive Surgical makes robotic-assisted, minimally invasive surgery technology.
Friedman is an emeritus Cancer Center director of City of Hope, a Duarte, Calif.-based cancer research, treatment and education institution. He was the president and CEO of City of Hope from May 2003 to December 2013 and holder of the Irell & Manella Cancer Center Director’s Distinguished Chair. Before leading City of Hope, from September 2001 until April 2003, Friedman held the position of senior vice president of research and development, medical and public policy, for Pharmacia Corporation and from July 1999 until September 2001, was a senior vice president of Searle, a subsidiary of Monsanto Company. From 1995 until June 1999, he served as deputy commissioner for operations for the U.S. Food and Drug Administration, and was acting commissioner and lead deputy commissioner from 1997 to 1999.
"Dr. Friedman has tremendous industry experience expertise that will be a valuable addition to Intuitive Surgical Board discussions", said Gary Guthart, Ph.D., president and CEO of Intuitive Surgical. "We look forward to welcoming him to our board."
Friedman has served on the board of directors of Celgene Corporation since February 2011, of MannKind Corporation since December 2003, and of Smith & Nephew plc since April 2013.
He graduated with a bachelor of arts degree, magna cum laude from Tulane University in New Orleans, La., and a doctorate in medicine from the University of Texas. He completed postdoctoral training at Stanford University and the National Cancer Institute, and is board certified in internal medicine and medical oncology.
Intuitive Surgical makes robotic-assisted, minimally invasive surgery technology.